ABSTRACT Background Hyaluronic acid (HA)‐based injectables are generally considered safe. However, short‐ and long‐term complications may occur. Objective To evaluate complications related to soft‐tissue augmentation presented to the Department of Dermatology at a university hospital. Materials and Methods A retrospective analysis was conducted using electronic medical records from January 2019 to January 2025. Adverse events related to HA‐based injectables, their management, and outcomes were identified and evaluated. Results Thirty‐one patients (mean age: 50.4 years) were included in the analysis. Injections have been administered by cosmeticians (2/31), nonmedical practitioners (2/31), or individuals of unknown qualification. The most common complications were biofilm formation and chronic immune reactions, followed by abscesses, Tyndall effect, vascular occlusion, and filler migration. Over half of the products involved were either uncertified or of unknown origin. Conclusion The findings highlight the need for qualified practitioners, careful product selection, and adherence to standardized techniques. Enhancing practitioner education, establishing evidence‐based protocols, and strengthening regulatory oversight are essential to ensure patient safety in aesthetic medicine.
Nguyen et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: